Navigation Links
Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property
Date:6/29/2009

BATESVILLE, Ind., June 29 /PRNewswire-FirstCall/ -- Hill-Rom (NYSE: HRC) today announced the sale of Hill-Rom's patents and intellectual property relating to Negative Pressure Wound Therapy (NPWT) to Kinetic Concepts, Inc. (NYSE: KCI). Hill-Rom's NPWT portfolio included U.S. and foreign patents and patent applications covering innovations to NPWT components, protocols, and related therapies. The transaction is effective immediately. Terms were not disclosed.

"The sale of these assets is a continuation of our portfolio rationalization initiative to more tightly focus on our core competencies and businesses that offer attractive and profitable growth opportunities for our shareholders," said Peter H. Soderberg, president and CEO, Hill-Rom Holdings. "While we have successfully developed valuable IP in the area of NPWT, the disposition of these assets is in line with our corporate strategy."

"KCI remains squarely focused on patient care and creating new alternatives in advanced wound healing and other areas," said Catherine M. Burzik, KCI President and Chief Executive Officer. "We will continue to make investments that put us in position to innovate and to deliver great alternatives to the medical community and patients."

ABOUT HILL-ROM

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care provi
'/>"/>

SOURCE Hill-Rom
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
3. Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Vestiage, Inc. ... company focused on science-based research and development, sales ... cosmeceuticals and nutraceuticals, announced today that it is ... for the sale of Reluma Skin Illuminating Facial ... and application by sending an email to info(at)vestiageinc(dot)com ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan ... human cord blood stem cell banking and therapeutics, announced ... the No. 16 Acorn Stairlifts Indy car driven by ... the remainder of the IZOD IndyCar 2013 season.   ... will work to support awareness of umbilical cord blood ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. ... for pain has reached an important milestone, as Virobay ... VBY-036 - a selective cathepsin S inhibitor.   ... a double-blind, randomized, placebo-controlled study designed to evaluate the ... VBY-036 in healthy adults. "The initiation of ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
... April 25 ,Renovis, Inc. (Nasdaq: RNVS ), ... Services have joined ISS/Risk Metrics and Glass Lewis,& ... the merger,agreement with Evotec AG (Frankfurt Stock Exchange: ... May 1, 2008. In the proposed merger,each share ...
... Corporation,of America (Nasdaq: DCAI ) announced today that ... May 7, 2008, after the close of the,market. The ... with,its first quarter 2008 earnings release the following morning, ... in participating in the May 8, 2008 conference call,may ...
... The Fraunhofer Center for,Manufacturing Innovation, Boston ... Nanoscience and Nanobiotechnology hosted the prestigious Society,of ... of their world class,facilities located on the ... tour included demonstrations of their new technological,advancements ...
Cached Biology Technology:Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec 2Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec 3Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date 2Fraunhofer and Boston University Hosted Prestigious SME Tour 2
(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...
(Date:5/23/2013)... new report from the Institute of Medicine says schools ... least 60 minutes of vigorous or moderate intensity activity ... of American youth meet current evidence-based guidelines of at ... activity daily, according to the report, which was released ... nearly half of their waking hours, the committee recommends ...
(Date:5/23/2013)... the interplay of brain chemicals which help us pay ... BBSRC. , By changing the way neurons respond ... these changes can affect the strength of a neuronal ... response. , Lead author Alex Thiele, Professor ... you can make yourself better heard by speaking louder ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide students with daily physical activity, IOM recommends 2
... -- Howard A. Schmidt, national cybersecurity coordinator and special assistant ... the 2010 IEEE International Conference on Technologies for Homeland Security ... and Christopher Doyle of the U.S. Department of Homeland Security ... featured speakers. HST 10 will be held at ...
... break you." If Rice University scientists wrote country songs, their ... this song wouldn,t break anybody,s heart. A new paper ... environmentally friendly way to make bulk quantities of graphene oxide ... use in all kinds of material and electronic applications. ...
... Medical School research team led by Kalpna Gupta, Ph.D., ... ease the chronic and acute pain caused by sickle ... SCD, Gupta and University of Minnesota colleagues studied the ... pain and temperature sensitivity, symptoms similarly experienced by humans ...
Cached Biology News:Graphene oxide gets green 2Graphene oxide gets green 3UM researcher identifies novel treatment for pain in sickle cell disease 2
... 5'G AATTC3' 3'CTTAA G5' Inactivation Conditions: Heat inactivation ... Storage Conditions: 10mM Tris-HCl (pH 7.5), 100mM KCl, ... BSA, 50% glycerol. Shipping and Storage: Shipped on ... unit is defined as the amount of enzyme ...
... stainless-steel shaker flask clips, purpose-designed to firmly ... All clips are equipped with a top ... include a bottom retainer spring, and silicon ... expensive glassware. Clips include the required ...
ANTI DIPHTH TOX A SU...
... Assay Kit (E-22013) provides,researchers with a ... lysozyme,activity in solution. This fluorescence-based assay ... U/mL (Figure 1). The assay,measures lysozyme ... are labeled to such a degree ...
Biology Products: